Liabilities and Equity in USD of WINDTREE THERAPEUTICS INC /DE/ from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly Liabilities and Equity history and change rate from Q4 2010 to Q3 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Liabilities and Equity for the quarter ending 30 Sep 2025 was $15,983,000, a 48% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,983,000 -$14,465,000 -48% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $31,826,000 +$3,119,000 +11% 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $26,766,000 -$3,337,000 -11% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $27,875,000 -$4,531,000 -14% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $30,448,000 -$5,609,000 -16% 30 Sep 2024 10-Q 26 Nov 2024 2024 Q3
Q2 2024 $28,707,000 -$11,868,000 -29% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $30,103,000 -$5,082,000 -14% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $32,406,000 -$5,548,000 -15% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $36,057,000 -$12,041,000 -25% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $40,575,000 -$11,238,000 -22% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $35,185,000 -$31,923,000 -48% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $37,954,000 -$36,835,000 -49% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $48,098,000 -$36,727,000 -43% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $51,813,000 -$39,052,000 -43% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $67,108,000 -$68,785,000 -51% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $74,789,000 -$38,096,000 -34% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $84,825,000 -$33,706,000 -28% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $90,865,000 -$37,458,000 -29% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $135,893,000 +$22,900,000 +20% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $112,885,000 -$6,090,000 -5.1% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $118,531,000 +$17,899,000 +18% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $128,323,000 +$23,078,000 +22% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $112,993,000 +$1,367,000 +1.2% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $118,975,000 -$423,000 -0.35% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $100,632,000 +$98,689,000 +5079% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $105,245,000 +$103,266,000 +5218% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $111,626,000 +$108,659,000 +3662% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 $119,398,000 +$116,051,000 +3467% 31 Dec 2018 10-K 03 Apr 2020 2019 FY
Q3 2018 $1,943,000 -$2,714,000 -58% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $1,979,000 -$3,846,000 -66% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $2,967,000 -$8,740,000 -75% 31 Mar 2018 10-Q 21 May 2018 2018 Q1
Q4 2017 $3,347,000 -$6,352,000 -65% 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
Q3 2017 $4,657,000 -$11,777,000 -72% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $5,825,000 -$19,173,000 -77% 30 Jun 2017 10-Q 21 Aug 2017 2017 Q2
Q1 2017 $11,707,000 -$23,003,000 -66% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $9,699,000 -$34,678,000 -78% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $16,434,000 -$36,298,000 -69% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $24,998,000 -$3,202,000 -11% 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 $34,710,000 -$3,412,000 -9% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 $44,377,000 -$3,122,000 -6.6% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $52,732,000 -$5,577,000 -9.6% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $28,200,000 -$41,274,000 -59% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $38,122,000 -$41,376,000 -52% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $47,499,000 -$41,818,000 -47% 31 Dec 2014 10-K 29 Mar 2016 2015 FY
Q3 2014 $58,309,000 +$34,678,000 +147% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $69,474,000 +$35,567,000 +105% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $79,498,000 +$50,336,000 +173% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 $89,317,000 +$59,374,000 +198% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $23,631,000 -$16,121,000 -41% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $33,907,000 -$15,274,000 -31% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $29,162,000 -$28,576,000 -49% 31 Mar 2013 10-Q 07 May 2013 2013 Q1
Q4 2012 $29,943,000 +$16,619,000 +125% 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q3 2012 $39,752,000 +$21,029,000 +112% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 $49,181,000 +$23,933,000 +95% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 $57,738,000 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 $13,324,000 -$1,213,000 -8.3% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 $18,723,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $25,248,000 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 $14,537,000 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.